Many Saudi MERS-CoV cases still involve contact with camels or drinking raw camel milk.
Comprehensive biomedical research must continue its crucial role in preparing the world for the next pandemic or other far-reaching public health emergency, whether it be caused by a novel influenza strain, Ebola, or some other transmissible pathogen, Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID) and colleagues wrote in a commentary in the Journal
The Saudi Arabian Ministry of Health (MOH) announced a new case of MERS-CoV today.
The patient is a 72-year-old man from Tabuk, a city in northwestern Saudi Arabia near the Jordanian border. He presented with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus) infection and is in stable condition. The man had direct contact with camels, a known risk factor for contracting MERS.
After a lag in reporting last week, the Saudi Arabian Ministry of Health (MOH) updated it information on MERS-CoV cases over the weekend, noting three new cases since the agency last reported on Sep 25.
Animal health officials in Vietnam have detected a highly pathogenic H5N6 avian flu outbreak in poultry, and South Korean authorities have found the H7N7 strain in wild bird droppings at a location in the south, according to media reports flagged by Avian Flu Diary, an infectious disease news blog.
In an update late last week, the US Centers for Disease Control and Prevention (CDC) said the multistate Cyclospora outbreak now involves 1,031 cases, 43 more cases than in the previous update on Sep 13.
The Saudi Arabian Ministry of Health (MOH) reported two new cases of MERS-CoV in Al Hofuf late last week, one of which was fatal. These are the first cases reported by the MOH in 10 days.
On Sep 21, the MOH confirmed that a 48-year-old Saudi man with direct camel contact was diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus) infection after presenting with MERS symptoms. He is in stable condition.
The United Arab Emirates (UAE) reported a new case of MERS-CoV to the World Health Organization (WHO), according to a WHO update yesterday.
A 78-year-old man from Al Ain was hospitalized on Aug 11 with symptoms of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. The man was not a healthcare worker, but no other details of his exposure or risk factors were available at this time.
EpiVax, Inc., a vaccine development and immune engineering company based in Providence, R.I., yesterday announced it is part of collaboration supported by a $5.8 million award from the National Institutes of Health (NIH) to develop a new type of vaccine against H7N9 avian influenza.
In addition, Oman reports its first MERS case of the year, in a middle-aged man.
